ERIS Lifesciences consolidated net profit declines 11.33% in the June 2022 quarter

Sales rise 14.08% to Rs 392.05 crore

Net profit of ERIS Lifesciences declined 11.33% to Rs 94.58 crore in the quarter ended June 2022 as against Rs 106.66 crore during the previous quarter ended June 2021. Sales rose 14.08% to Rs 392.05 crore in the quarter ended June 2022 as against Rs 343.66 crore during the previous quarter ended June 2021. ParticularsQuarter EndedJun. 2022Jun. 2021% Var.Sales392.05343.66 14 OPM %32.9536.81 -PBDT124.71131.60 -5 PBT101.27117.10 -14 NP94.58106.66 -11

Powered by Capital Market - Live News